Different CD44 splicing patterns define prognostic subgroups in multiple myeloma

Blood

Volumn 88, Issue 8, 1996, Pages 3101-3108

  Stauder, R ^a   Van Driel, M ^b   Schwarzler C ^b   Thaler, J ^b   Lokhorst, H M ^b   Kreuser, E D ^b   Bloem, A C ^b   Gunthert U ^b   Eisterer, W ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; INTERLEUKIN 6; NUCLEAR RNA; PROTEIN;

ADULT; AGED; ARTICLE; CELL SELECTION; EXON; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SOUTHERN BLOTTING;

EID: 0029907810     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.3101.bloodjournal8883101     Document Type: Article

References (38)

1. Günthert U: CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47, 1993
2. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54:271, 1993
3. Pals ST, Koopman G, Griffioen A, Ponta H, Herrlich P, van den Berg F, Horst E: CD44: A variety of isoforms with functions in cell adhesion and tumor metastasis, in Shimizu Y (ed): Lymphocyte Adhesion Molecules. Austin, TX, R.G. Landes, 1993, p 135
4. Stauder R, Günthert U: CD44 isoforms - Impact on lymphocyte activation and differentiation. Immunologist 3:26, 1995
5. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
6. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zöller M: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443, 1993
7. Bartolazzi A, Jackson D, Bennett K, Aruffo A, Dickinson R, Shields J, Whittle N, Stamenkovic I: Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 108:1723, 1995
8. Günthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K: Are CD44 variant isoforms involved in human tumour progression? Cancer Surv 24:19, 1995
9. Günthert U: CD44 in malignant disorders. Curr Top Microbiol Immunol 213/I:271, 1996
10. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897, 1993
11. Salles G, Zain M, Jiang WM, Boussiotis VA, Shipp MA: Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: Characterization and comparison with normal activated B cells and epithelial malignancies. Blood 82:3539, 1993
12. Terpe HJ, Koopmann R, Imhof BA, Günthert U: Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 174:89, 1994
13. Stauder R, Eisterer W, Thaler J, Günthert U: CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor. Blood 85:2885, 1995
14. Ristamäki R, Joensuu H, Söderström K-O, Jalkanen J: CD44v6 expression in non-Hodgkin' lymphoma: An association with low histological grade and poor prognosis. J Pathol 176:259. 1995
15. Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC: Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood 82:3712, 1993
16. Kim I, Uchiyama H, Chauhan D, Anderson KC: Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br J Haematol 87:483, 1994
17. Lokhorst HM, Lamme T, de Smet M, Klein S, de Weger R, van Oers R, Bloem AC: Primary tumor cells of myeloma patients induce IL-6 secretion in long term bone marrow cultures. Blood 84:2269, 1994
18. Degrassi A, Hilbert DM, Rudikoff S, Anderson AO, Potter M, Coon HG: In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc Natl Acad Sci USA 90:2060, 1993
19. Dune BGM: Staging and kinetics of multiple myeloma. Semin Oncol 13:1300, 1986
20. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71, 1994
21. Mackay CR, Maddox JF, Wijffels GL, Mackay R, Walker ID: Characterization of a 95000 molecule on sheep leucocytes homologous to murine Pgp-1 and human CD44. Immunology 65:93, 1988
22. Miller CH, Carbonell A, Peng R, Paglieroni T, Mackenzie MR: A human plasma cell line: Induction and characterization. Cancer 49:2091, 1982
23. Eisterer W, Hilbe W, Stauder R, Bechter O, Fend F, Thaler J: An aggressive subtype of B-cell chronic lymphocytic leukaemia (B-CLL) is characterized by CD44 upregulation and lack of CD11c. Br J Haematol 93:661, 1996
24. Mayer B, Jauch KW, Günthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP: De-novo expression of CD44 and survival in gastric cancer. Lancet 342:1019, 1993
25. Terpe H-J. Christiansen H, Gonzales M, Berthold F, Lampert F: Expression of CD44 isoforms in renal cell tumors: Positive correlation to tumor progression. Am J Pathol 148:453, 1996
26. Galluzo E, Albi N, Fiorucci S, Merigiola C, Ruggeri L, Tosti A, Grossi CE, Velardi A: Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T-cells. Eur J Immunol 25:2932, 1995
27. Ghaffari S, Dougherty GJ, Lansdorp PM, Eaves AC, Eaves CJ: Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 86:2976, 1995
28. Kryworuckho M, Diaz-Mitoma F, Kumar A: CD44 isoforms containing exons v6 and v7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B-cells. Immunology 86:41, 1995
29. Hirano H, Screaton GR, Bell MV, Jackson DG, Bell JI, Hodes RJ: CD44 isoform expression mediated by alternative splicing: Tissue-specific regulation in mice. Int Immunol 6:49, 1993
30. Turley EA, Belch AJ, Poppema S, Pilarski LM: Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood 81:446, 1993
31. Hofmann M, Rudy W, Günthert U, Zimmer SG, Zawadzki V, Zöller M, Lichtner RB, Herrlich P, Ponta H: A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53:1516, 1993
32. Jamal HH, Cano-Gauci DF, Buick RN, Filmus J: Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells. Oncogene 9:417, 1994
33. Corradini P, Ladetto M, Inghirami G, Boccadoro M, Pileri A: N- and K-ras oncogenes in plasma cell dyscrasias. Leuk Lymphoma 15:17, 1994
34. Billadeau D, Jelinek DF, Shah N, LeBien TW, Van Ness BV: Introduction of an activated N-ras oncogene alters the growth characterstics of the Interleukin 6-dependent myeloma cell line ANBL6. Cancer Res 55:3640, 1995
35. Underhill C: CD44: The hyaluronan receptor. J Cell Sci 103:293, 1992
36. Stamenkovic I, Aruffo A: Hyaluronic acid receptors. Methods Enzymol 245:195, 1994
37. Miyake K, Medina KL, Hayashi S, Ono S, Hamaoka T, Kincade PW: Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171:477, 1990
38. Dougherty GJ, Cooper DL, Memory JF, Chiu RK: Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. J Biol Chem 269:9074, 1994